Form D · Other Technology

Cardea Bio, Inc.

San Diego, CA · CIK 0001626157

Offering snapshot reported Sep 22, 2020 · SEC filing

Reported sold
$1.7M
Offering amount: $9.21M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 11, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 22, 2020Initial$1,699,999No comparison2SEC filing
Apr 15, 2019Initial$7,404,429No comparison54SEC filing
Apr 17, 2017Initial$550,000No comparison7SEC filing
Jul 13, 2016Initial$425,000No comparison6SEC filing
Jan 21, 2016Initial$600,000No comparison12SEC filing
May 5, 2015Initial$1,075,000No comparison15SEC filing
Nov 21, 2014Initial$200,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-375960

Source: Form D, filed Sep 22, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ross Bundy Director, Executive
Brett Goldsmith Director, Executive
Paul Grint Director
Biao He Director
Michael Heltzen Director, Executive
Tim Hoerr Director
Jonathan Kabakoff Director
Joseph Keegan Director
Nina Saberi Director

Issuer details

Industry: Other Technology (See others in industry)

Address:
9640 Town Centre Drive, Suite 100
San Diego, CA, 92121